Serina Therapeutics, Inc. Q2 FY2021 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2021 Q2 Call date: 2021-08-13 Concluded

Quarter scorecard

Revenue

$37,000

-17.8% YoY

Gross margin

64.9%

-28.4 pp YoY

Net income

Other Revenues $26,000

+188.9%

Grant Revenues $11,000

-69.4%